nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ACE—psoriatic arthritis	0.551	1	CbGaD
Captopril—ALB—Auranofin—psoriatic arthritis	0.0959	0.364	CbGbCtD
Captopril—ALB—Prednisone—psoriatic arthritis	0.0305	0.116	CbGbCtD
Captopril—ABCB1—Methylprednisolone—psoriatic arthritis	0.0264	0.1	CbGbCtD
Captopril—SLC22A6—Methotrexate—psoriatic arthritis	0.018	0.0682	CbGbCtD
Captopril—ABCB1—Betamethasone—psoriatic arthritis	0.0171	0.065	CbGbCtD
Captopril—ABCB1—Prednisolone—psoriatic arthritis	0.0169	0.0642	CbGbCtD
Captopril—ABCB1—Prednisone—psoriatic arthritis	0.016	0.0606	CbGbCtD
Captopril—ALB—Methotrexate—psoriatic arthritis	0.0153	0.0581	CbGbCtD
Captopril—MMP9—synovial fluid—psoriatic arthritis	0.0152	0.224	CbGeAlD
Captopril—F2—knee—psoriatic arthritis	0.0119	0.176	CbGeAlD
Captopril—MMP2—skeletal joint—psoriatic arthritis	0.0113	0.167	CbGeAlD
Captopril—ABCB1—Dexamethasone—psoriatic arthritis	0.00997	0.0378	CbGbCtD
Captopril—MMP9—skeletal joint—psoriatic arthritis	0.00981	0.145	CbGeAlD
Captopril—CYP2D6—Dexamethasone—psoriatic arthritis	0.0094	0.0356	CbGbCtD
Captopril—ABCB1—Methotrexate—psoriatic arthritis	0.00801	0.0304	CbGbCtD
Captopril—F2—vertebral column—psoriatic arthritis	0.0068	0.101	CbGeAlD
Captopril—ACE—skeletal joint—psoriatic arthritis	0.00523	0.0773	CbGeAlD
Captopril—REN—Metabolism of Angiotensinogen to Angiotensins—ACE—psoriatic arthritis	0.00347	0.25	CbGpPWpGaD
Captopril—REN—ACE Inhibitor Pathway—ACE—psoriatic arthritis	0.00331	0.238	CbGpPWpGaD
Captopril—Enalapril—ACE—psoriatic arthritis	0.00276	1	CrCbGaD
Captopril—LTA4H—tendon—psoriatic arthritis	0.00183	0.027	CbGeAlD
Captopril—MMP2—skin of body—psoriatic arthritis	0.0017	0.0252	CbGeAlD
Captopril—MMP9—skin of body—psoriatic arthritis	0.00148	0.0219	CbGeAlD
Captopril—MMP2—ATF-2 transcription factor network—IL23A—psoriatic arthritis	0.00144	0.104	CbGpPWpGaD
Captopril—MMP2—tendon—psoriatic arthritis	0.0013	0.0192	CbGeAlD
Captopril—MMP9—tendon—psoriatic arthritis	0.00113	0.0167	CbGeAlD
Captopril—REN—Peptide hormone metabolism—ACE—psoriatic arthritis	0.000913	0.0657	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—NOS2—psoriatic arthritis	0.000352	0.0253	CbGpPWpGaD
Captopril—MMP2—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000324	0.105	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000324	0.105	CbGdCrCtD
Captopril—MMP2—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000321	0.0231	CbGpPWpGaD
Captopril—MMP2—Dexamethasone—Betamethasone—psoriatic arthritis	0.000319	0.104	CbGdCrCtD
Captopril—MMP2—Betamethasone—Dexamethasone—psoriatic arthritis	0.000319	0.104	CbGdCrCtD
Captopril—MMP2—Betamethasone—Triamcinolone—psoriatic arthritis	0.000312	0.101	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000312	0.101	CbGdCrCtD
Captopril—MMP2—Matrix Metalloproteinases—TNF—psoriatic arthritis	0.0003	0.0216	CbGpPWpGaD
Captopril—MMP2—Betamethasone—Prednisone—psoriatic arthritis	0.000296	0.0961	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisone—psoriatic arthritis	0.000296	0.0961	CbGdCrCtD
Captopril—MMP2—Dexamethasone—Prednisolone—psoriatic arthritis	0.000289	0.0938	CbGdCrCtD
Captopril—MMP2—Betamethasone—Prednisolone—psoriatic arthritis	0.000289	0.0938	CbGdCrCtD
Captopril—MMP2—amb2 Integrin signaling—TNF—psoriatic arthritis	0.000285	0.0205	CbGpPWpGaD
Captopril—Polyuria—Methotrexate—psoriatic arthritis	0.000221	0.00226	CcSEcCtD
Captopril—Cardiac arrest—Prednisone—psoriatic arthritis	0.000221	0.00226	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.000219	0.0158	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.000211	0.0152	CbGpPWpGaD
Captopril—Renal failure acute—Methotrexate—psoriatic arthritis	0.00021	0.00215	CcSEcCtD
Captopril—Weight decreased—Betamethasone—psoriatic arthritis	0.000208	0.00213	CcSEcCtD
Captopril—Weight decreased—Dexamethasone—psoriatic arthritis	0.000208	0.00213	CcSEcCtD
Captopril—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000206	0.0021	CcSEcCtD
Captopril—Muscular weakness—Prednisone—psoriatic arthritis	0.000205	0.00209	CcSEcCtD
Captopril—Rhinitis—Triamcinolone—psoriatic arthritis	0.000204	0.00208	CcSEcCtD
Captopril—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000203	0.00208	CcSEcCtD
Captopril—Hallucination—Methylprednisolone—psoriatic arthritis	0.000202	0.00206	CcSEcCtD
Captopril—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000202	0.00206	CcSEcCtD
Captopril—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.0002	0.00205	CcSEcCtD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000199	0.0143	CbGpPWpGaD
Captopril—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000198	0.00202	CcSEcCtD
Captopril—Pancreatitis—Prednisone—psoriatic arthritis	0.000197	0.00201	CcSEcCtD
Captopril—MMP9—Matrix Metalloproteinases—TNF—psoriatic arthritis	0.000197	0.0141	CbGpPWpGaD
Captopril—Neutropenia—Prednisone—psoriatic arthritis	0.000188	0.00192	CcSEcCtD
Captopril—MMP9—amb2 Integrin signaling—TNF—psoriatic arthritis	0.000187	0.0134	CbGpPWpGaD
Captopril—Erectile dysfunction—Prednisone—psoriatic arthritis	0.000185	0.00189	CcSEcCtD
Captopril—Hallucination—Dexamethasone—psoriatic arthritis	0.000183	0.00188	CcSEcCtD
Captopril—Hallucination—Betamethasone—psoriatic arthritis	0.000183	0.00188	CcSEcCtD
Captopril—MMP9—CXCR4-mediated signaling events—HLA-DRB1—psoriatic arthritis	0.000183	0.0131	CbGpPWpGaD
Captopril—Ataxia—Methotrexate—psoriatic arthritis	0.000182	0.00187	CcSEcCtD
Captopril—Weight decreased—Prednisone—psoriatic arthritis	0.000182	0.00186	CcSEcCtD
Captopril—Vision blurred—Prednisolone—psoriatic arthritis	0.000181	0.00185	CcSEcCtD
Captopril—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000179	0.00183	CcSEcCtD
Captopril—F2—Folate Metabolism—CRP—psoriatic arthritis	0.000178	0.0128	CbGpPWpGaD
Captopril—Angioedema—Prednisolone—psoriatic arthritis	0.000176	0.0018	CcSEcCtD
Captopril—Malaise—Prednisolone—psoriatic arthritis	0.000173	0.00177	CcSEcCtD
Captopril—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000173	0.00177	CcSEcCtD
Captopril—Syncope—Prednisolone—psoriatic arthritis	0.000173	0.00176	CcSEcCtD
Captopril—REN—Metabolism of proteins—ACE—psoriatic arthritis	0.000172	0.0124	CbGpPWpGaD
Captopril—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000169	0.00173	CcSEcCtD
Captopril—Eosinophilia—Methotrexate—psoriatic arthritis	0.000166	0.0017	CcSEcCtD
Captopril—Pancreatitis—Methotrexate—psoriatic arthritis	0.000164	0.00168	CcSEcCtD
Captopril—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000164	0.00168	CcSEcCtD
Captopril—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000164	0.00168	CcSEcCtD
Captopril—Alopecia—Betamethasone—psoriatic arthritis	0.000163	0.00167	CcSEcCtD
Captopril—Alopecia—Dexamethasone—psoriatic arthritis	0.000163	0.00167	CcSEcCtD
Captopril—Discomfort—Prednisolone—psoriatic arthritis	0.000162	0.00165	CcSEcCtD
Captopril—Angioedema—Triamcinolone—psoriatic arthritis	0.000162	0.00165	CcSEcCtD
Captopril—Angioedema—Methylprednisolone—psoriatic arthritis	0.000161	0.00165	CcSEcCtD
Captopril—Hallucination—Prednisone—psoriatic arthritis	0.00016	0.00163	CcSEcCtD
Captopril—Malaise—Triamcinolone—psoriatic arthritis	0.00016	0.00163	CcSEcCtD
Captopril—Pancytopenia—Methotrexate—psoriatic arthritis	0.000159	0.00163	CcSEcCtD
Captopril—Malaise—Methylprednisolone—psoriatic arthritis	0.000159	0.00163	CcSEcCtD
Captopril—Syncope—Triamcinolone—psoriatic arthritis	0.000159	0.00162	CcSEcCtD
Captopril—Syncope—Methylprednisolone—psoriatic arthritis	0.000158	0.00162	CcSEcCtD
Captopril—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000157	0.00161	CcSEcCtD
Captopril—Neutropenia—Methotrexate—psoriatic arthritis	0.000157	0.0016	CcSEcCtD
Captopril—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000156	0.00159	CcSEcCtD
Captopril—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000155	0.00159	CcSEcCtD
Captopril—Shock—Prednisolone—psoriatic arthritis	0.000154	0.00158	CcSEcCtD
Captopril—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000154	0.00158	CcSEcCtD
Captopril—Cough—Triamcinolone—psoriatic arthritis	0.000154	0.00158	CcSEcCtD
Captopril—Tachycardia—Prednisolone—psoriatic arthritis	0.000153	0.00157	CcSEcCtD
Captopril—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000153	0.00157	CcSEcCtD
Captopril—Myalgia—Triamcinolone—psoriatic arthritis	0.000151	0.00154	CcSEcCtD
Captopril—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00015	0.00154	CcSEcCtD
Captopril—Myalgia—Methylprednisolone—psoriatic arthritis	0.00015	0.00154	CcSEcCtD
Captopril—MMP9—TWEAK Signaling Pathway—TNF—psoriatic arthritis	0.00015	0.0108	CbGpPWpGaD
Captopril—Flushing—Prednisone—psoriatic arthritis	0.000149	0.00152	CcSEcCtD
Captopril—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000149	0.00152	CcSEcCtD
Captopril—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000149	0.00152	CcSEcCtD
Captopril—Discomfort—Triamcinolone—psoriatic arthritis	0.000149	0.00152	CcSEcCtD
Captopril—Discomfort—Methylprednisolone—psoriatic arthritis	0.000148	0.00152	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000148	0.00152	CcSEcCtD
Captopril—Dry mouth—Triamcinolone—psoriatic arthritis	0.000147	0.00151	CcSEcCtD
Captopril—Renal failure—Methotrexate—psoriatic arthritis	0.000147	0.0015	CcSEcCtD
Captopril—Angioedema—Betamethasone—psoriatic arthritis	0.000147	0.0015	CcSEcCtD
Captopril—Angioedema—Dexamethasone—psoriatic arthritis	0.000147	0.0015	CcSEcCtD
Captopril—Stomatitis—Methotrexate—psoriatic arthritis	0.000146	0.00149	CcSEcCtD
Captopril—Confusional state—Methylprednisolone—psoriatic arthritis	0.000145	0.00149	CcSEcCtD
Captopril—Malaise—Betamethasone—psoriatic arthritis	0.000145	0.00148	CcSEcCtD
Captopril—Malaise—Dexamethasone—psoriatic arthritis	0.000145	0.00148	CcSEcCtD
Captopril—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000144	0.00148	CcSEcCtD
Captopril—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000144	0.00147	CcSEcCtD
Captopril—Syncope—Dexamethasone—psoriatic arthritis	0.000144	0.00147	CcSEcCtD
Captopril—Syncope—Betamethasone—psoriatic arthritis	0.000144	0.00147	CcSEcCtD
Captopril—Shock—Triamcinolone—psoriatic arthritis	0.000142	0.00145	CcSEcCtD
Captopril—Insomnia—Prednisolone—psoriatic arthritis	0.000142	0.00145	CcSEcCtD
Captopril—Alopecia—Prednisone—psoriatic arthritis	0.000142	0.00145	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000142	0.0102	CbGpPWpGaD
Captopril—Shock—Methylprednisolone—psoriatic arthritis	0.000142	0.00145	CcSEcCtD
Captopril—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000141	0.00144	CcSEcCtD
Captopril—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000141	0.00144	CcSEcCtD
Captopril—Paraesthesia—Prednisolone—psoriatic arthritis	0.000141	0.00144	CcSEcCtD
Captopril—Tachycardia—Triamcinolone—psoriatic arthritis	0.000141	0.00144	CcSEcCtD
Captopril—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000141	0.00144	CcSEcCtD
Captopril—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00014	0.00143	CcSEcCtD
Captopril—Myalgia—Betamethasone—psoriatic arthritis	0.000137	0.0014	CcSEcCtD
Captopril—Myalgia—Dexamethasone—psoriatic arthritis	0.000137	0.0014	CcSEcCtD
Captopril—Discomfort—Betamethasone—psoriatic arthritis	0.000135	0.00138	CcSEcCtD
Captopril—Discomfort—Dexamethasone—psoriatic arthritis	0.000135	0.00138	CcSEcCtD
Captopril—Hypotension—Methylprednisolone—psoriatic arthritis	0.000135	0.00138	CcSEcCtD
Captopril—Hepatitis—Methotrexate—psoriatic arthritis	0.000134	0.00137	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—psoriatic arthritis	0.000133	0.00136	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—NOS2—psoriatic arthritis	0.000132	0.00953	CbGpPWpGaD
Captopril—Vision blurred—Prednisone—psoriatic arthritis	0.000132	0.00135	CcSEcCtD
Captopril—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000132	0.00135	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000131	0.00134	CcSEcCtD
Captopril—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000131	0.00134	CcSEcCtD
Captopril—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000131	0.00134	CcSEcCtD
Captopril—Insomnia—Triamcinolone—psoriatic arthritis	0.000131	0.00134	CcSEcCtD
Captopril—Insomnia—Methylprednisolone—psoriatic arthritis	0.00013	0.00133	CcSEcCtD
Captopril—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00013	0.00133	CcSEcCtD
Captopril—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00013	0.00133	CcSEcCtD
Captopril—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000129	0.00132	CcSEcCtD
Captopril—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000129	0.00132	CcSEcCtD
Captopril—Anaemia—Prednisone—psoriatic arthritis	0.000129	0.00132	CcSEcCtD
Captopril—Shock—Dexamethasone—psoriatic arthritis	0.000129	0.00132	CcSEcCtD
Captopril—Shock—Betamethasone—psoriatic arthritis	0.000129	0.00132	CcSEcCtD
Captopril—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000129	0.00132	CcSEcCtD
Captopril—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000128	0.00131	CcSEcCtD
Captopril—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000128	0.00131	CcSEcCtD
Captopril—Tachycardia—Betamethasone—psoriatic arthritis	0.000128	0.00131	CcSEcCtD
Captopril—Tachycardia—Dexamethasone—psoriatic arthritis	0.000128	0.00131	CcSEcCtD
Captopril—Angioedema—Prednisone—psoriatic arthritis	0.000128	0.00131	CcSEcCtD
Captopril—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000127	0.0013	CcSEcCtD
Captopril—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000127	0.0013	CcSEcCtD
Captopril—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000127	0.0013	CcSEcCtD
Captopril—Malaise—Prednisone—psoriatic arthritis	0.000126	0.00129	CcSEcCtD
Captopril—Syncope—Prednisone—psoriatic arthritis	0.000125	0.00128	CcSEcCtD
Captopril—Anorexia—Dexamethasone—psoriatic arthritis	0.000125	0.00128	CcSEcCtD
Captopril—Anorexia—Betamethasone—psoriatic arthritis	0.000125	0.00128	CcSEcCtD
Captopril—Fatigue—Triamcinolone—psoriatic arthritis	0.000124	0.00127	CcSEcCtD
Captopril—Fatigue—Methylprednisolone—psoriatic arthritis	0.000124	0.00127	CcSEcCtD
Captopril—Loss of consciousness—Prednisone—psoriatic arthritis	0.000123	0.00126	CcSEcCtD
Captopril—Hypotension—Betamethasone—psoriatic arthritis	0.000122	0.00125	CcSEcCtD
Captopril—Hypotension—Dexamethasone—psoriatic arthritis	0.000122	0.00125	CcSEcCtD
Captopril—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000119	0.00122	CcSEcCtD
Captopril—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000119	0.00122	CcSEcCtD
Captopril—Arthralgia—Prednisone—psoriatic arthritis	0.000119	0.00122	CcSEcCtD
Captopril—Myalgia—Prednisone—psoriatic arthritis	0.000119	0.00122	CcSEcCtD
Captopril—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000119	0.00122	CcSEcCtD
Captopril—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000119	0.00121	CcSEcCtD
Captopril—Alopecia—Methotrexate—psoriatic arthritis	0.000119	0.00121	CcSEcCtD
Captopril—Insomnia—Dexamethasone—psoriatic arthritis	0.000119	0.00121	CcSEcCtD
Captopril—Insomnia—Betamethasone—psoriatic arthritis	0.000119	0.00121	CcSEcCtD
Captopril—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000118	0.0012	CcSEcCtD
Captopril—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000118	0.0012	CcSEcCtD
Captopril—Paraesthesia—Betamethasone—psoriatic arthritis	0.000118	0.0012	CcSEcCtD
Captopril—Discomfort—Prednisone—psoriatic arthritis	0.000118	0.0012	CcSEcCtD
Captopril—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000115	0.00118	CcSEcCtD
Captopril—Dyspepsia—Betamethasone—psoriatic arthritis	0.000115	0.00118	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—psoriatic arthritis	0.000114	0.00117	CcSEcCtD
Captopril—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000114	0.00117	CcSEcCtD
Captopril—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000114	0.00117	CcSEcCtD
Captopril—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000114	0.00116	CcSEcCtD
Captopril—Decreased appetite—Betamethasone—psoriatic arthritis	0.000114	0.00116	CcSEcCtD
Captopril—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000114	0.00116	CcSEcCtD
Captopril—Fatigue—Betamethasone—psoriatic arthritis	0.000113	0.00116	CcSEcCtD
Captopril—Fatigue—Dexamethasone—psoriatic arthritis	0.000113	0.00116	CcSEcCtD
Captopril—Shock—Prednisone—psoriatic arthritis	0.000112	0.00115	CcSEcCtD
Captopril—Tachycardia—Prednisone—psoriatic arthritis	0.000111	0.00114	CcSEcCtD
Captopril—Vision blurred—Methotrexate—psoriatic arthritis	0.00011	0.00113	CcSEcCtD
Captopril—Anorexia—Prednisone—psoriatic arthritis	0.000109	0.00111	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000108	0.00111	CcSEcCtD
Captopril—Anaemia—Methotrexate—psoriatic arthritis	0.000108	0.0011	CcSEcCtD
Captopril—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000108	0.0011	CcSEcCtD
Captopril—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000108	0.0011	CcSEcCtD
Captopril—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000107	0.0011	CcSEcCtD
Captopril—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000107	0.0011	CcSEcCtD
Captopril—Malaise—Methotrexate—psoriatic arthritis	0.000105	0.00108	CcSEcCtD
Captopril—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000104	0.00106	CcSEcCtD
Captopril—Dizziness—Prednisolone—psoriatic arthritis	0.000104	0.00106	CcSEcCtD
Captopril—Asthenia—Triamcinolone—psoriatic arthritis	0.000104	0.00106	CcSEcCtD
Captopril—Abdominal pain—Betamethasone—psoriatic arthritis	0.000104	0.00106	CcSEcCtD
Captopril—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000104	0.00106	CcSEcCtD
Captopril—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000104	0.00106	CcSEcCtD
Captopril—Body temperature increased—Betamethasone—psoriatic arthritis	0.000104	0.00106	CcSEcCtD
Captopril—Asthenia—Methylprednisolone—psoriatic arthritis	0.000103	0.00106	CcSEcCtD
Captopril—Insomnia—Prednisone—psoriatic arthritis	0.000103	0.00106	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—HLA-C—psoriatic arthritis	0.000103	0.00739	CbGpPWpGaD
Captopril—Paraesthesia—Prednisone—psoriatic arthritis	0.000102	0.00105	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—IL13—psoriatic arthritis	0.000102	0.00735	CbGpPWpGaD
Captopril—Pruritus—Triamcinolone—psoriatic arthritis	0.000102	0.00104	CcSEcCtD
Captopril—Cough—Methotrexate—psoriatic arthritis	0.000102	0.00104	CcSEcCtD
Captopril—Pruritus—Methylprednisolone—psoriatic arthritis	0.000102	0.00104	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriatic arthritis	0.000101	0.00726	CbGpPWpGaD
Captopril—Dyspepsia—Prednisone—psoriatic arthritis	0.0001	0.00103	CcSEcCtD
Captopril—Arthralgia—Methotrexate—psoriatic arthritis	9.95e-05	0.00102	CcSEcCtD
Captopril—Myalgia—Methotrexate—psoriatic arthritis	9.95e-05	0.00102	CcSEcCtD
Captopril—Chest pain—Methotrexate—psoriatic arthritis	9.95e-05	0.00102	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—TNF—psoriatic arthritis	9.93e-05	0.00714	CbGpPWpGaD
Captopril—Decreased appetite—Prednisone—psoriatic arthritis	9.92e-05	0.00101	CcSEcCtD
Captopril—Rash—Prednisolone—psoriatic arthritis	9.9e-05	0.00101	CcSEcCtD
Captopril—Dermatitis—Prednisolone—psoriatic arthritis	9.89e-05	0.00101	CcSEcCtD
Captopril—Diarrhoea—Methylprednisolone—psoriatic arthritis	9.86e-05	0.00101	CcSEcCtD
Captopril—Fatigue—Prednisone—psoriatic arthritis	9.84e-05	0.00101	CcSEcCtD
Captopril—Headache—Prednisolone—psoriatic arthritis	9.84e-05	0.00101	CcSEcCtD
Captopril—Discomfort—Methotrexate—psoriatic arthritis	9.83e-05	0.00101	CcSEcCtD
Captopril—Constipation—Prednisone—psoriatic arthritis	9.76e-05	0.000998	CcSEcCtD
Captopril—Confusional state—Methotrexate—psoriatic arthritis	9.61e-05	0.000983	CcSEcCtD
Captopril—Dizziness—Triamcinolone—psoriatic arthritis	9.55e-05	0.000976	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—psoriatic arthritis	9.54e-05	0.000975	CcSEcCtD
Captopril—Dizziness—Methylprednisolone—psoriatic arthritis	9.53e-05	0.000974	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—IL17A—psoriatic arthritis	9.4e-05	0.00676	CbGpPWpGaD
Captopril—Feeling abnormal—Prednisone—psoriatic arthritis	9.4e-05	0.000962	CcSEcCtD
Captopril—Asthenia—Dexamethasone—psoriatic arthritis	9.4e-05	0.000961	CcSEcCtD
Captopril—Asthenia—Betamethasone—psoriatic arthritis	9.4e-05	0.000961	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—psoriatic arthritis	9.34e-05	0.000955	CcSEcCtD
Captopril—Gastrointestinal pain—Prednisone—psoriatic arthritis	9.33e-05	0.000954	CcSEcCtD
Captopril—Nausea—Prednisolone—psoriatic arthritis	9.33e-05	0.000954	CcSEcCtD
Captopril—Pruritus—Dexamethasone—psoriatic arthritis	9.27e-05	0.000948	CcSEcCtD
Captopril—Pruritus—Betamethasone—psoriatic arthritis	9.27e-05	0.000948	CcSEcCtD
Captopril—Vomiting—Triamcinolone—psoriatic arthritis	9.18e-05	0.000939	CcSEcCtD
Captopril—Vomiting—Methylprednisolone—psoriatic arthritis	9.16e-05	0.000937	CcSEcCtD
Captopril—Rash—Triamcinolone—psoriatic arthritis	9.1e-05	0.000931	CcSEcCtD
Captopril—Dermatitis—Triamcinolone—psoriatic arthritis	9.1e-05	0.00093	CcSEcCtD
Captopril—Anorexia—Methotrexate—psoriatic arthritis	9.09e-05	0.00093	CcSEcCtD
Captopril—Rash—Methylprednisolone—psoriatic arthritis	9.08e-05	0.000929	CcSEcCtD
Captopril—Dermatitis—Methylprednisolone—psoriatic arthritis	9.08e-05	0.000928	CcSEcCtD
Captopril—Headache—Triamcinolone—psoriatic arthritis	9.05e-05	0.000925	CcSEcCtD
Captopril—Headache—Methylprednisolone—psoriatic arthritis	9.03e-05	0.000923	CcSEcCtD
Captopril—Body temperature increased—Prednisone—psoriatic arthritis	9.02e-05	0.000922	CcSEcCtD
Captopril—Abdominal pain—Prednisone—psoriatic arthritis	9.02e-05	0.000922	CcSEcCtD
Captopril—Diarrhoea—Dexamethasone—psoriatic arthritis	8.96e-05	0.000917	CcSEcCtD
Captopril—Diarrhoea—Betamethasone—psoriatic arthritis	8.96e-05	0.000917	CcSEcCtD
Captopril—Hypotension—Methotrexate—psoriatic arthritis	8.91e-05	0.000911	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—IL12B—psoriatic arthritis	8.74e-05	0.00629	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—CRP—psoriatic arthritis	8.71e-05	0.00626	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	8.69e-05	0.000888	CcSEcCtD
Captopril—Dizziness—Betamethasone—psoriatic arthritis	8.66e-05	0.000886	CcSEcCtD
Captopril—Dizziness—Dexamethasone—psoriatic arthritis	8.66e-05	0.000886	CcSEcCtD
Captopril—Insomnia—Methotrexate—psoriatic arthritis	8.62e-05	0.000882	CcSEcCtD
Captopril—Nausea—Triamcinolone—psoriatic arthritis	8.58e-05	0.000877	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—psoriatic arthritis	8.56e-05	0.000876	CcSEcCtD
Captopril—MMP2—Metabolism of proteins—ACE—psoriatic arthritis	8.56e-05	0.00616	CbGpPWpGaD
Captopril—Nausea—Methylprednisolone—psoriatic arthritis	8.56e-05	0.000875	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—psoriatic arthritis	8.5e-05	0.000869	CcSEcCtD
Captopril—Somnolence—Methotrexate—psoriatic arthritis	8.48e-05	0.000867	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—psoriatic arthritis	8.39e-05	0.000858	CcSEcCtD
Captopril—Vomiting—Dexamethasone—psoriatic arthritis	8.33e-05	0.000852	CcSEcCtD
Captopril—Vomiting—Betamethasone—psoriatic arthritis	8.33e-05	0.000852	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—psoriatic arthritis	8.29e-05	0.000848	CcSEcCtD
Captopril—Rash—Dexamethasone—psoriatic arthritis	8.26e-05	0.000845	CcSEcCtD
Captopril—Rash—Betamethasone—psoriatic arthritis	8.26e-05	0.000845	CcSEcCtD
Captopril—Dermatitis—Betamethasone—psoriatic arthritis	8.25e-05	0.000844	CcSEcCtD
Captopril—Dermatitis—Dexamethasone—psoriatic arthritis	8.25e-05	0.000844	CcSEcCtD
Captopril—Fatigue—Methotrexate—psoriatic arthritis	8.22e-05	0.000841	CcSEcCtD
Captopril—Headache—Dexamethasone—psoriatic arthritis	8.21e-05	0.000839	CcSEcCtD
Captopril—Headache—Betamethasone—psoriatic arthritis	8.21e-05	0.000839	CcSEcCtD
Captopril—Asthenia—Prednisone—psoriatic arthritis	8.19e-05	0.000837	CcSEcCtD
Captopril—F2—Folate Metabolism—TNF—psoriatic arthritis	8.08e-05	0.00581	CbGpPWpGaD
Captopril—Pruritus—Prednisone—psoriatic arthritis	8.07e-05	0.000826	CcSEcCtD
Captopril—Feeling abnormal—Methotrexate—psoriatic arthritis	7.86e-05	0.000804	CcSEcCtD
Captopril—Diarrhoea—Prednisone—psoriatic arthritis	7.81e-05	0.000798	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—psoriatic arthritis	7.8e-05	0.000797	CcSEcCtD
Captopril—Nausea—Betamethasone—psoriatic arthritis	7.78e-05	0.000796	CcSEcCtD
Captopril—Nausea—Dexamethasone—psoriatic arthritis	7.78e-05	0.000796	CcSEcCtD
Captopril—Dizziness—Prednisone—psoriatic arthritis	7.55e-05	0.000772	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—psoriatic arthritis	7.54e-05	0.000771	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—psoriatic arthritis	7.54e-05	0.000771	CcSEcCtD
Captopril—Vomiting—Prednisone—psoriatic arthritis	7.25e-05	0.000742	CcSEcCtD
Captopril—Rash—Prednisone—psoriatic arthritis	7.19e-05	0.000736	CcSEcCtD
Captopril—Dermatitis—Prednisone—psoriatic arthritis	7.19e-05	0.000735	CcSEcCtD
Captopril—Headache—Prednisone—psoriatic arthritis	7.15e-05	0.000731	CcSEcCtD
Captopril—ALB—Folate Metabolism—CRP—psoriatic arthritis	7.08e-05	0.00509	CbGpPWpGaD
Captopril—Asthenia—Methotrexate—psoriatic arthritis	6.84e-05	0.0007	CcSEcCtD
Captopril—Nausea—Prednisone—psoriatic arthritis	6.78e-05	0.000693	CcSEcCtD
Captopril—Pruritus—Methotrexate—psoriatic arthritis	6.75e-05	0.00069	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—TNF—psoriatic arthritis	6.57e-05	0.00473	CbGpPWpGaD
Captopril—Diarrhoea—Methotrexate—psoriatic arthritis	6.52e-05	0.000667	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—TNF—psoriatic arthritis	6.42e-05	0.00462	CbGpPWpGaD
Captopril—Dizziness—Methotrexate—psoriatic arthritis	6.31e-05	0.000645	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—HLA-B—psoriatic arthritis	6.08e-05	0.00437	CbGpPWpGaD
Captopril—Vomiting—Methotrexate—psoriatic arthritis	6.06e-05	0.00062	CcSEcCtD
Captopril—Rash—Methotrexate—psoriatic arthritis	6.01e-05	0.000615	CcSEcCtD
Captopril—Dermatitis—Methotrexate—psoriatic arthritis	6.01e-05	0.000614	CcSEcCtD
Captopril—Headache—Methotrexate—psoriatic arthritis	5.97e-05	0.000611	CcSEcCtD
Captopril—Nausea—Methotrexate—psoriatic arthritis	5.66e-05	0.000579	CcSEcCtD
Captopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	5.66e-05	0.00407	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CRP—psoriatic arthritis	5.63e-05	0.00405	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—HLA-DRB1—psoriatic arthritis	5.15e-05	0.0037	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ACE—psoriatic arthritis	4.34e-05	0.00312	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—psoriatic arthritis	3.94e-05	0.00283	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—psoriatic arthritis	3.21e-05	0.00231	CbGpPWpGaD
Captopril—F2—Hemostasis—NOS2—psoriatic arthritis	3.19e-05	0.00229	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—psoriatic arthritis	3.19e-05	0.00229	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—psoriatic arthritis	2.55e-05	0.00183	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	2.43e-05	0.00175	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—psoriatic arthritis	2.09e-05	0.0015	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—psoriatic arthritis	1.27e-05	0.000911	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	1.2e-05	0.000863	CbGpPWpGaD
